A detailed history of Aton Ra Partners transactions in Inari Medical, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 4,193 shares of NARI stock, worth $213,717. This represents 0.54% of its overall portfolio holdings.

Number of Shares
4,193
Previous 4,577 8.39%
Holding current value
$213,717
Previous $299,000 9.03%
% of portfolio
0.54%
Previous 0.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$48.3 - $68.06 $18,547 - $26,135
-384 Reduced 8.39%
4,193 $272,000
Q3 2023

Oct 25, 2023

SELL
$54.2 - $71.67 $5,962 - $7,883
-110 Reduced 2.35%
4,577 $299,000
Q2 2023

Jul 18, 2023

SELL
$56.23 - $71.17 $60,166 - $76,151
-1,070 Reduced 18.59%
4,687 $272,000
Q1 2023

May 05, 2023

SELL
$53.43 - $68.12 $43,224 - $55,109
-809 Reduced 12.32%
5,757 $355,000
Q4 2022

Feb 02, 2023

BUY
$61.23 - $83.62 $402,036 - $549,048
6,566 New
6,566 $417,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.72B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.